Sector ratings Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-01-24			5-day change	1st Jan Change
180,200.00 ^KRW	+0.61%		-0.99%	-3.89%

08:45pm	Celltrion Launches SteQeyma Across Five European Countries	MT
Jan. 14	Celltrion Unveils Strategic Vision for Advancing Its Innovative Drug Pipeline At the 43Rd Annual J.P. Morgan Healthcare Conference	CI

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG MSCI	Capi. ($)
CELLTRION, INC.		B	26.47B
LONZA GROUP AG		AAA	46.39B
IQVIA HOLDINGS INC.		AA	37.39B
ICON PUBLIC LIMITED COMPANY		AA	16.73B
UNITED THERAPEUTICS CORPORATION		BBB	16.6B
MODERNA, INC.	-	AA	16.31B
BIO-TECHNE CORPORATION		A	12.22B
MEDPACE HOLDINGS, INC.		BBB	10.79B
QIAGEN N.V.		AAA	10.19B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		A	8.53B
REVOLUTION MEDICINES, INC.	-	B	7.6B
BLUEPRINT MEDICINES CORPORATION		B	7.35B
TELIX PHARMACEUTICALS LIMITED		A	5.65B
PHARMARON BEIJING CO., LTD.		AA	5.6B
IONIS PHARMACEUTICALS, INC.	-	BB	5.44B
HANGZHOU TIGERMED CONSULTING CO., LTD		AA	5.35B
ALKERMES PLC		A	5.14B
BACHEM HOLDING AG		BBB	4.84B
Average		A	13.81B
Weighted average by Cap.		A